President's Message—December 2018

Michele Calos, Ph.D. - December 13, 2018

As you may have seen in recent emails from ASGCT, registration for the 2019 Annual Meeting—our 22nd—is now open!

Personally, I’m honored to lead ASGCT through what is already shaping up to be our largest meeting in Society history. The support we receive from the field through attendance, sponsorship, and awards is surpassed only by the enthusiasm of our members and the excitement surrounding the science presented during the meeting. Because of that support, ASGCT is able to offer free registration to Associate Members who are first and presenting authors of abstracts during the Annual Meeting.

Whether or not you’re submitting an abstract, please consider booking your room in the ASGCT room block at the host hotel, the Washington Hilton, sooner rather than later. The ASGCT block sells out well before the meeting every year and is the way ASGCT can guarantee a discounted room rate for the Annual Meeting.

Finally, all of us at ASGCT extend our deepest condolences to the family, friends, and colleagues of Dr. Brian Sorrentino. A pioneer in our field, Dr. Sorrentino led a research team at St. Jude Children’s Hospital developing novel gene therapies for babies born with X-linked severe combined immunodeficiency.

Dr. Phillip Doerfler, editor of The Vector and a colleague of Sorrentino’s at St. Jude, has written a personal, moving remembrance of Sorrentino on behalf of ASGCT which we’ve published in this edition of The Vector and on the ASGCT blog. Thank you, Phillip, for sharing what Brian meant to our field and celebrating his life and accomplishments.

Michele Calos, Ph.D.
ASGCT President

ASGCT Policy Summit
November 4 – 6 | Washington D.C.